Allergic Reactions to Medicines Derived from Pelargonium Species
Tóm tắt
Pelargonium (Pelargonium sidoides DC and P. reniforme Curtis) is reported to have immune modulating properties and antibacterial activity, and Pelargonium extracts have been used for the treatment of respiratory tract and gastrointestinal infections. Introduced in the early 1980s in Germany, Umckaloabo® (ISO Arzneimittel), an ethanolic extract of the roots of P. sidoides and P. reniforme, was the first Pelargonium- derived product to be commonly used in a country in the EU. According to the Umckaloabo® product information, this extract has no known adverse effects. However, there is a theoretical risk of interactions with anticoagulants such as warfarin, and antiplatelet drugs, such as aspirin (acetylsalicylic acid). To date, the Uppsala Monitoring Centre has, through the WHO international pharmacovigilance programme, received 34 case reports of allergic reactions suspected to be associated with the use of Pelargonium extract, all originating from Germany. In a number of these reports, the description and timing of the event was indicative of an acute Coombs and Gell Type I hypersensitivity reaction; two of these patients needed treatment for circulatory failure. So far, the experience of such reactions is limited to Germany. Since Pelargonium- containing herbal products have recently been approved in a number of other countries, the possibility of the occurrence of allergic reactions has become of more general interest and further information regarding these products is needed.
Tài liệu tham khảo
Dreyer LL, Marais EM. Section reniformia: a new section in the genus Pelargonium (Geraniaceae). S Afr J Bot 2000; 66(1): 44–51
von Bojanowski W. Das biologische tuberculosemittel umckaloabo. Fortschr Med 1937; 35(11): 141–4
Arznei-telegramm 2003; 34: 37 [online]. Available from URL: http://www.arznei-telegramm.de/zeit/0303_a.php3?. [Accessed 2007 Mar 19]
ISO-Arzneimittel: Fachinformation UMCKALOABO, Stand 2002 Feb
Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore (NY) 2005; 1(6): 437–45
Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multi-centre study. Curr Med Res Opin 2007; 23(2): 323–31
Olsson S. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf 1998 Jul; 19(1): 1–10
Data on file, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). Bonn, Germany
Fernandez de Corres L, Corrales JL, Munoz D, et al. Allergic contact dermatitis caused by plants. Allergol Immunopathol (Madr) 1984; 12(4): 313–9
Paulsen E, Skov PS, Andersen KE. Immediate skin and mucosal symptoms from pot plants and vegetables in gardeners and greenhouse workers. Contact Derm 1998; 39(4): 166–70
Tsyrkunov LP. Toxiderma resulting from occupational contact with Pelargonium. Vestn Dermatol Venerol 1989; 7: 65–6